Zobrazeno 71 - 80
of 80 841
pro vyhledávání: ''
Autor:
R K Shandil, Nathella Pavankumar, Hemanth Kumar, Devaraju Reddy, Anant Mohan, Jaykumar Menon, L Sekar, Chandrasekaran Padmapriydarsini, Metrif Team, P. Ramesh, Megha Mamulwar, Randeep Guleria, N S Gomathy, Prema Shanmugam, Shaheed M Jawahar, Chandra Suresh, Poornaganga Devi, Abhijeet Kadam, Manjula Singh, Urvashi B. Singh, Aarti Mane
Publikováno v:
Clinical Infectious Diseases. 75:425-434
Background Metformin, by reducing intracellular Mycobacterium tuberculosis growth, can be considered an adjunctive therapy to anti-tuberculosis treatment (ATT). We determined whether metformin with standard ATT reduces time to sputum culture conversi
Autor:
Sasisopin Kiertiburanakul, Ploenchan Chetchotisakd, Kiat Ruxrungtham, Lasa study team, Noppaket Singkham, Torsak Bunupuradah, Baralee Punyawudho, Angela K. Birnbaum, Anchalee Avihingsanon, Richard C. Brundage, Narukjaporn Thammajaruk
Publikováno v:
Expert Review of Clinical Pharmacology. 15:99-108
BACKGROUND This population pharmacokinetic-pharmacogenetic study aimed to investigate the optimal dose of RTV-boosted ATV (ATV/RTV) for Thai adult HIV-infected patients. METHODS A total of 1460 concentrations of ATV and RTV from 544 patients receivin
Autor:
José Padilla, Carlos Bravo-Pérez, Vicente Vicente, Rosa Cifuentes, María Eugenia de la Morena-Barrio, Belén de la Morena-Barrio, Pedro Garrido, Antonia Miñano, Javier Corral
Publikováno v:
American Journal of Hematology. 97:216-225
Antithrombin deficiency, the most severe thrombophilia, might be underestimated, since it is only investigated in cases with consistent functional deficiency or family history. We have analyzed 444 consecutive, unrelated cases, from 1998 to 2021, wit
Autor:
Yang Zhu, Shu Tian, Hua Zhong, Wenhao Zhang, Lifeng Wang, Rong Tao, Zhi-Chao Li, Hao Ding, Lina Jin, Chuanying Zhu, Yu-Jie Ma, Chuan-xu Liu, Siguo Hao, Lan Xu
Publikováno v:
British Journal of Haematology. 196:939-946
Early-stage natural killer/T-cell lymphoma (NK/TCL) patients usually receive a combination of chemotherapy and radiotherapy, but the optimal treatment approach has not yet been established. This study aimed to investigate the efficacy and safety prof
Autor:
Ana Paula Negreiros Nunes Alves, Anna Clara Aragão Matos Carlos, Paulo Goberlânio de Barros Silva, Cássia Emanuella Nóbrega Malta, Eveline Fernandes Alves E Silva, Manuele Carine Maciel de Alencar, José Fernando Bastos de Moura, Fábio Figueiredo Chaves, Victor Bruno Caitano Nogueira
Publikováno v:
Supportive Care in Cancer. 30:2569-2580
To evaluate the effectiveness of photobiomodulation (PBMT) in preventing dysgeusia in breast cancer patients treated with doxorubicin-cyclophosphamide (AC). This is a phase II, randomized, triple-blind, placebo-controlled clinical trial involving 112
Autor:
Blanca Polo, Maria Joao Costa, Ana Vagos Mata, C. Lopes, João F. Lacerda, Daniela Alves, Eduardo Espada, João Raposo
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 24, Pp 8768-8776 (2021)
Cancer Medicine, Vol 10, Iss 24, Pp 8768-8776 (2021)
High‐dose methylprednisolone plus rituximab (R‐HDMP) is a useful treatment in chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) patients unfit for chemo‐immunotherapy and has proven its utility on the treatment of CLL/SLL compl
Publikováno v:
BioMed Research International, Vol 2021 (2021)
BioMed Research International
BioMed Research International
Objective. This study was designed to explore the clinical efficacy of methotrexate combined with iguratimod on patients with rheumatoid arthritis (RA) and its influence on the expression levels of HOTAIR in serum. Methods. A total of 268 RA patients
Publikováno v:
Leuk Lymphoma
Relapsed/refractory Primary Central Nervous System Lymphoma (R/R PCNSL) has a poor prognosis with no established preferred treatment. We report the efficacy and toxicity of a combination chemotherapy regimen: methotrexate, carmustine, etoposide, and
Autor:
Ali Unlu, Gulsum Abusoglu, Fatma Humeyra Yerlikaya, Dilek Tezcan, Duygu Eryavuz Onmaz, Sema Yilmaz, Mustafa Onmaz, Sedat Abusoglu
Publikováno v:
Inflammopharmacology
Hydroxychloroquine has attracted attention in the treatment of COVID-19. Many conflicting findings have been reported regarding the efficacy and safety of this drug, which has been used safely in the rheumatological diseases for years. However, these
Autor:
Xiaomin Huang, Xiang Ji, Pengfei Pan, Lisheng Xu, Qian Qi, Yu Li, Mingtao Liu, Fengjuan Wu, Zhiyun Xu, Peng Jiang, Ruyue Zhao
Publikováno v:
Thoracic Cancer, Vol 12, Iss 24, Pp 3416-3425 (2021)
Thoracic Cancer
Thoracic Cancer
Background The aim of the study was to assess the efficacy and side‐effects of intrapleural treatment in non‐small cell lung cancer (NSCLC) patients with malignant pleural effusions (MPEs). Methods The medical records of NSCLC patients with MPEs